Browse All

Current Filters

CLEAR FILTER x

TITLE

Switching to Subcutaneous Zilucoplan from Intravenous Complement Component 5 Inhibitors in Myasthenia Gravis: Patient Preference and Satisfaction from a Phase 3b Study

Author:Freimer, Miriam   Desai, Urvi   Govindarajan, Raghav   Kang, Min K.   Khan, Shaida   Khatri, Bhupendra   Levine, Todd   Macwan, Samir   Shieh, Perry B.   Weiss, Michael D.   Bloemers, Jos   Boroojerdi, Babak   Delicha, Eumorphia Maria   Lavrov, Andreea   Singh, Puneet   Howard Jr., Ja   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.009  

Author Institution:The Ohio State University Wexner Medical Center, Columbus, OH, USA, Columbus, OH  Atrium Health, Wake Forest University, Charlotte, NC, USA, Charlotte, NC  HSHS St. Elizabeth’s Hospital, O’Fallon, IL, USA, O'Fallon, IL  University of California, San Francisco, San Francisco, CA, USA, San Francisco, CA  UT Southwestern Medical Center, Dallas, TX, USA, Dallas, TX  The Regional MS Center and Center for Neurological Disorders, Milwaukee, WI, USA, Milwaukee, WI  HonorHealth Neurology, Bob Bové Neuroscience Institute, Scottsdale, AZ, USA, Scottsdale, AZ  Eisenhower Health, Rancho Mirage, CA, USA, Rancho Mirage, CA  University of California, Los Angeles, Los Angeles, CA, USA, Los Angeles, CA  University of Washington Medical Center, Seattle, WA, USA, Seattle, WA  UCB, Brussels, Belgium, Brussels, Belgium  UCB, Monheim, Germany, Monheim, Germany  UCB, Braine-l’Alleud, Belgium, Braine-l’Alleud, Belgium  UCB, Slough, UK, Slough , United Kingdom  The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, Chapel Hill, NC  

Correlation Between MG Symptoms PRO and Existing MG-Specific Outcome Scores in the Phase 3 MycarinG Study: Post Hoc Analysis

Author:Pascuzzi, Robert M.   Antozzi, Carlo   Habib, Ali A.   Kaminski, Henry J.   Sacconi, Sabrina   Utsugisawa, Kimiaki   Vissing, John   Regnault, Antoine   Bloemers, Jos   Grimson, Fiona   Tarancón, Thaïs   Bril, Vera   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.026  

Author Institution:Neurology Department, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USA, Indianapolis, IN  Neuroimmunology and Muscle Pathology Unit, Multiple Sclerosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  MDA ALS & Neuromuscular Center, Department of Neurology, University of California, Irvine, Orange, CA, USA, Orange, CA  Department of Neurology & Rehabilitation Medicine, George Washington University, Washington, DC, USA, Washington, DC  Université Côte d'Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  Modus Outcomes, A Division of THREAD, Lyon, France, Lyon , France  UCB, Brussels, Belgium, Brussels, Belgium  UCB, Slough, UK, Slough, United Kingdom  UCB, Madrid, Spain, Madrid, Spain  University Health Network, Toronto, ON, Canada, Toronto, ON, Canada